INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...

I've had no side effects, and I'm monitoring my progress through continued research studies. My doctors tell me I'm "buying ...

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its shares ...

After an Alzheimer's diagnosis, many find themselves looking for answers but not knowing where to turn. A new app aims to ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

An Alzheimer’s diagnosis can be devastating and confusing. The recently released Alzheimer's Association app My ALZ Journey ...

Instead, identifying early-stage individuals necessitates biomarker-based screening, which adds layers of complexity to an ...

Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...

A new study led by scientists from BGI Genomics' Institute of Intelligent Medical Research (IIMR) has identified early ...

Help Black families facing dementia. Join SHARE, a clinical trial for support, health, activities, resources, and education.

Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...

South Carolina is creating a statewide network for researching and treating Alzheimer's disease even as advocates lobby for ...